Candel Therapeutics Inc (CADL) — Defensive Interval Ratio

Latest as of December 2020: 0 days

Candel Therapeutics Inc (CADL) has a Defensive Interval Ratio of 0 days as of December 2020. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $12.91K/day. See CADL working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

0 days
Days of operational coverage

Defensive Assets

$0.00
Cash + ST Investments + Receivables

Daily Cash Need

$12.91K
Current Liabilities ÷ 365

Current Liabilities

$4.71 Million
USD

Candel Therapeutics Inc Defensive Interval Ratio (2019–2020)

This chart shows how Candel Therapeutics Inc's Defensive Interval Ratio has evolved across 2 annual periods from 2019 to 2020. As of December 2020, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. See net asset quality index of Candel Therapeutics Inc to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Candel Therapeutics Inc (2019–2020)

The table below presents the year-by-year Defensive Interval Ratio for Candel Therapeutics Inc from 2019 to 2020, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Candel Therapeutics Inc.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2020 0 days $0.00 $12.91K/day $- $0.00 ▼ -10323 days
2019 10323 days $39.88 Million $3.86K/day $- $39.88 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)